COMMUNIQUÉS West-GlobeNewswire

Zosano Pharma to Host Conference Call on Third Quarter 2018 Financial Results and Provide Operational Update
07/11/2018
FREMONT, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and [...]
Clearside Biomedical to Participate in Stifel 2018 Healthcare Conference
07/11/2018
ALPHARETTA, Ga., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
MyoKardia Reports Third Quarter 2018 Financial Results
07/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today [...]
Sarepta Therapeutics Announces Proposed $500,000,000 Public Offering of Common Stock
07/11/2018
CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, today announced that it is offering to sell, subject to market and [...]
Catalyst Pharmaceuticals Announces Third Quarter 2018 Financial Results and Provides Corporate Update
07/11/2018
Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow CORAL GABLES, Fla., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and [...]
Osiris Therapeutics, Inc Reports Third Quarter 2018 Results
07/11/2018
COLUMBIA, Md., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, [...]
Fluidigm Recognized as a Company to Watch in 2019
07/11/2018
Immuno-oncology innovator receives life science people’s choice award SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- BioInformatics Inc., the leading research and advisory firm serving the life science [...]
Inovalon Reports Third Quarter 2018 Results
07/11/2018
Third Quarter 2018 Highlights Q3 revenue of $145.8 million Q3 net loss of $0.8 million, resulting in net loss of $0.01 per share Q3 Non-GAAP net income of $16.3 million, resulting in Non-GAAP net income of $0.11 per [...]
Voyager Therapeutics Announces Positive Longer-Term Data for VY-AADC for Parkinson’s Disease
07/11/2018
One-time treatment with VY-AADC demonstrates durable improvements in motor function at 18 months and beyond from ongoing Phase 1b trial CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. ( [...]
Voyager Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Highlights
07/11/2018
One-time treatment with VY-AADC demonstrates durable improvements in motor function at 18 months and beyond from ongoing Phase 1b trial Recent preclinical results for Huntington’s disease and Amyotrophic Lateral [...]
Aileron Therapeutics Reports Third Quarter 2018 Financial Results
07/11/2018
Manuel Aivado, MD, PhD, promoted to President and Chief Executive Officer Vojislav Vukovic, MD, appointed Senior Vice President, Chief Medical Officer, and Allen Annis, PhD, promoted to Senior Vice President, Research [...]
Foamix Reports Third Quarter 2018 Financial Results and Provides Corporate Update
07/11/2018
Conference Call and Webcast Thursday, November 8, @ 8.30 am Eastern Time REHOVOT, Israel, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) (“Foamix” or the “Company”), a clinical stage [...]
Zafgen Reports Third Quarter 2018 Operating and Financial Results
07/11/2018
ZGN-1061 1.8 mg cohort for the Phase 2 proof-of-concept trial now fully enrolled; on track for topline results early 2019 ZGN-1258 nonclinical safety and efficacy data sets presented at Foundation for Prader-Willi [...]
Codexis to Present at Two Investment Conferences in November
07/11/2018
REDWOOD CITY, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at two upcoming investment conferences: 9 th Annual [...]
Axovant Announces Second Fiscal Quarter 2018 Financial Results and Corporate Updates
07/11/2018
First patient dosed in clinical study of AXO-Lenti-PD, a novel gene therapy for treatment of Parkinson’s disease Expanded pipeline of gene therapies with in-licensing of AXO-AAV-OPMD for treatment of oculopharyngeal [...]
Opiant Pharmaceuticals, Inc. Reports Third Quarter 2018 Financial Results and Provides Corporate Update
07/11/2018
SANTA MONICA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, [...]
MediWound to Host Third Quarter 2018 Financial Results Conference Call on November 13 at 8:30 a.m. Eastern Time
07/11/2018
YAVNE, Israel, Nov. 07, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]
Calithera Biosciences Reports Third Quarter 2018 Financial Results and Recent Highlights
07/11/2018
-Calithera to Host Conference Call Today at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage [...]
Menlo Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business Update
07/11/2018
~ Phase 2 Data in Psoriasis Expected December 2018 ~ ~ New Phase 2 Clinical Trial in Chronic Pruritus of Unknown Origin Expected to Start in Q4 2018 ~ ~ Prurigo Nodularis Phase 3 Clinical Trials Enrolling in U.S. and [...]

Pages